Innovent Biologics Inc. (6IB)
Market Closed
3 Jun, 20:00
XFRA 
€
8. 4860
-0.136
-1.58%
€
15.45B Market Cap
- P/E Ratio
- Div Yield
100 Volume
0 Eps
€ 8.622
Previous Close Want to track 6IB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Innovent Biologics Inc. (6IB) Statistics
Valuation metrics
Market Cap 15.45B
Enterprise value -54.28M
Trailing P/E (ttm) 142.8
Forward P/E -
PEG ratio -
Price/Sales (ttm) 1.14
Price/Book (mrq) 6.07
Enterprise Value/Revenue -0.03
Enterprise Value/EBITDA -0.33
Overview
Shares outstanding 1.73B
Float 1.61B
Shares short -
% Held by insiders 0.06%
% Held by institutions 0.56%
Average volume (10 days) 127
Average volume (90 days) 523
Price summary
52-Week low 7.15
52-Week high 11.7
Beta 0.24
50-Day moving average 9.41
200-Day moving average 9.62
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.06%
Operating margin -0.01%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.05%
Income Statement
Revenue (ttm) 1.65B
Revenue per share (ttm) 7.77
Quarterly revenue growth (yoy) 0.3%
Gross profit (ttm) 1.26B
EBITDA 1.52B
Net income to common (ttm) 102.64M
Diluted EPS (ttm) 0.06
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 2.3B
Total cash per share (mrq) 10.51
Total debt (mrq) 355.24M
Total Debt/Equity (mrq) 14.55
Current ratio (mrq) 2.62%
Book value per share (mrq) 1.41
Cash Flow
Cash flow statement 1.26B
Levered free cash flow (LFCF) 407.26M
